NLRP3/caspase-1-dependent IL-1β/IL-18 release or NLRP3/caspase-1-dependent/GSDMD-mediated pyroptosis is crucial in inflammatory disease, autoimmune diseases, tissue injuries and other diseases [61–64]. This evidence concerns the gene CASP1 and autoimmune disease.